IP Verse

Compositions Comprising A Delivery Agent And Preparation Thereof - EP3542790

The patent EP3542790 was granted to Novo Nordisk on Sep 13, 2023. The application was originally filed on Mar 15, 2013 under application number EP18212576A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3542790

NOVO NORDISK
Application Number
EP18212576A
Filing Date
Mar 15, 2013
Status
Granted And Under Opposition
Aug 11, 2023
Grant Date
Sep 13, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (7)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ADALVOJun 13, 2024CASALPRIM CASTELLAADMISSIBLE
CMS CAMERON MCKENNA NABARRO OLSWANGJun 13, 2024CMS CAMERON MCKENNA NABARRO OLSWANGADMISSIBLE
GENERICS UKJun 13, 2024TER MEER STEINMEISTER & PARTNERADMISSIBLE
HEXALJun 13, 2024MAIWALDADMISSIBLE
KRAUS & LEDERER PARTGMBBJun 13, 2024KRAUS & LEDERER PARTGMBBADMISSIBLE
POLPHARMAJun 13, 2024MAIWALDADMISSIBLE
STRAWMANJun 12, 2024HOFFMANN EITLEADMISSIBLE

Patent Citations (48) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO0046182
DESCRIPTIONWO0192206
DESCRIPTIONWO2005027978
DESCRIPTIONWO2005058954
DESCRIPTIONWO2005058958
DESCRIPTIONWO2006005667
DESCRIPTIONWO2006037810
DESCRIPTIONWO2006037811
DESCRIPTIONWO2006097537
DESCRIPTIONWO2006097538
DESCRIPTIONWO2007121318
DESCRIPTIONWO2008023050
DESCRIPTIONWO2008028859
DESCRIPTIONWO2009030738
DESCRIPTIONWO2009030771
DESCRIPTIONWO2009030774
DESCRIPTIONWO2009083549
DESCRIPTIONWO9319175
DESCRIPTIONWO9629342
DESCRIPTIONWO9630036
DESCRIPTIONWO9808871
DESCRIPTIONWO9943341
DESCRIPTIONWO9943706
DESCRIPTIONWO9943707
DESCRIPTIONWO9943708
OPPOSITIONJP4585037B
OPPOSITIONNZ219575
OPPOSITIONUS2003083360
OPPOSITIONUS2008153779
OPPOSITIONUS2008255048
OPPOSITIONUS2009124639
OPPOSITIONUS2010069410
OPPOSITIONUS2011256220
OPPOSITIONUS4609675
OPPOSITIONWO02076376
OPPOSITIONWO2005107462
OPPOSITIONWO2005107773
OPPOSITIONWO2005115347
OPPOSITIONWO2006060711
OPPOSITIONWO2006084164
OPPOSITIONWO2006097537
OPPOSITIONWO2006124047
OPPOSITIONWO2012080471
OPPOSITIONWO2013139694
OPPOSITIONWO2013139695
OPPOSITIONWO2013189988
SEARCHUS2008153779
SEARCHUS2010069410

Non-Patent Literature (NPL) Citations (45) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- HODGSON et al., "The synthesis of peptides and proteins containing non-natural amino acids", Chemical Society Reviews, (20040000), vol. 33, no. 7, pages 422 - 430, XP008067398-
OPPOSITION- Ahmed Adel Sakr, Fars K. Alanazi , "Chapter 45- Oral Solid Dosage Forms ", Remington: The Science and Practice of Pharmacy 22nd Edition, Pharmaceutical Press , (20130101), pages 947 - 976, ISBN 978-0-85711-062-6, XP093002004-
OPPOSITION- Anonymous, "Emisphere Announces License Agreement With Novo Nordisk to Develop Oral Formulation of GLP-1 Receptor Agonists for Diabetes", Emisphere Technologies, Inc., (20080623), Emisphere Technologies, Inc., URL: https://www.medindia.net/health-press-release/Emisphere-Announces-License-Agreement-With-Novo-Nordisk-to-Develop-Oral-Formulation-of-GLP-1-Receptor-Agonists-for-Diabetes-24764-1.htm, XP093195850-
OPPOSITION- Anonymous, "Emisphere Technologies, Inc. Announces License Agreement With Novo Nordisk, Inc. to Develop Oral Formulation of GLP-1 Receptor Agonists for Diabetes", BioSpace, (20080623), BioSpace, URL: https://www.biospace.com/emisphere-technologies-inc-announces-license-agreement-with-novo-nordisk-inc-to-develop-oral-formulation-of-glp-1-receptor-agonists-for-diabetes, XP093193031-
OPPOSITION- Anonymous, "Granulation", Wikipedia, (20240108), pages 1 - 5, Wikipedia , URL: https://en.wikipedia.org/w/index.php?title=Granulation&oldid=1194323726, XP093169178-
OPPOSITION- Anonymous, "International Nonproprietary Names for Pharmaceutical Substances (INN)", WHO Drug Information, (20090101), vol. 23, no. 2, pages 129 - 192, XP055858023-
OPPOSITION- Anonymous, "Pharmaceutical Development Case Study: “ACE Tablets” (Version 2.0)", Conformia - CMC-IM Working Group, (20080313), Conformia - CMC-IM Working Group, URL: https://ispe.org/sites/default/files/initiatives/pqli/case-study-ace-tablets.pdf, XP093193151-
OPPOSITION- Anonymous, "Semaglutide", WHO Drug Information, (20090101), vol. 23, no. 2, page 164, XP055520576-
OPPOSITION- Anonymous, "Valtrex 500mg Tablets - Summary of Product Characteristics (SmPC)", (20190625), XP093193605-
OPPOSITION- Anonymous, "Valtrex overview", European Medicines Agency (EMA), (20210122), XP093193611-
OPPOSITION- Anonymous, "Valtrex® prescribing information", GlaxoSmithKline, (20071001), pages 1 - 20, GlaxoSmithKline, (20191024), XP055635480-
OPPOSITION- Bryan J Ennis, "Theory of Granulation: An Engineering Perspective", Handbook of pharmaceutical granulation technology Third edition , Informa healthcare , (20100101), pages 6 - 57, XP093169213-
OPPOSITION- D105- Auxiliary Request 3 in the appeal proceedings relating to EP 2 827 845 B1-
OPPOSITION- David B. Troy, "Chapter 45: Oral Solid Dosage Forms", David B. Troy, David B. Troy, Remington: The Science and Practice of Pharmacy, Lippincott Williams & Wilkins , (20050101), pages 889 - 928, ISBN 0781746736, XP009556366-
OPPOSITION- Dilip M. Parikh, "Chapter 1, Introduction", Handbook of Pharmaceutical Granulation Technology, Taylor & Francis Group, LLC , (20050101), pages 1 - 6, ISBN 0-8247-2647-2, XP055592603-
OPPOSITION- Dilip M. Parikh, "Theory of Granulation : An Engineering Perspective", Handbook of Pharmaceutical Granulation Technology third edition, (20050101), pages 7, 10 - 330, XP055592665-
OPPOSITION- Heather Rothwell, "Eligen@ Technology. Summary and Value Proposition", Emisphere, (20170224), pages 1 - 10, Emisphere, URL: https://www.emisphere.com/wp-content/uploads/2017/02/Eligen-Technology-Presentation_2.15-Update.pdf, (20181031), XP055520567-
OPPOSITION- Junginger Hans E., "Delivery Systeme für die perorale Applikation von Peptiden, Kapitel 1.2.", Junginger Hans E., Keck Cornelia M., Müller Rainer H., Moderne Pharmazeutische Technologie, (20090101), pages 8 - 14, XP093193023-
OPPOSITION- J WANG et al.,, "Lubrication in tablet formulations", European Journal of Pharmaceutics and Biopharmaceutics, (2010), vol. 75, XP027000715-
OPPOSITION- Kushner, J. ; Moore, F., "Scale-up model describing the impact of lubrication on tablet tensile strength", International Journal of Pharmaceutics, ELSEVIER, NL, NL , (20101031), vol. 399, no. 1-2, ISSN 0378-5173, pages 19 - 30, XP027298450-
OPPOSITION- Mary E Mohr; Et Al, "36 Separation p. 677; 45 Oral Solid Dosage Forms pp. 892-893; 46 Coating of Pharmaceutical Dosage Forms pp. 896; 55 Pharmaceutical Necessities pp. 1040", Mary E Mohr; Et Al, Gennaro, A.R.; Der Marderosian, A.H.; Hanson, G.R.; Medwick, T.; Popovich, N.G.; Schnaare, R.L.; Schwartz, J.B.; White, H.S., Remington: The Science and Practice of Pharmacy 20th Edition, Lippincott Williams , (20050101), pages 677, 892 - 893, 896, 1040, ISBN 0-683-30647-2, XP055635101-
OPPOSITION- Parikh, Dilip M., "Chapter 1. Introduction", Parikh, Dilip M., Dilip M. Parikh, Handbook of Pharmaceutical Granulation Technology. 3rd ed., N.Y., Informa Healthcare USA, Inc., (20100101), pages 1 - 5, ISBN 978-1-4398-0789-7, XP009556385-
OPPOSITION- Rajeev Gokhale, "Wet Granulation in Low- and High-Shear Mixers", Handbook of pharmaceutical granulation technology Third edition, Informa healthcare, (20100101), pages 183 - 203, Handbook of pharmaceutical granulation technology Third edition, XP093169230-
OPPOSITION- Remington J., "Chapter 45: Oral solid dosage forms", Remington: The Science and Practice of Pharmacy. 22nd ed., PhP , (20120101), page 947, XP055634446-
OPPOSITION- Ronald W Miller, "Roller Compaction Technology", Handbook of pharmaceutical granulation technology Third edition, Informa healthcare, (20100101), pages 163 - 182, XP093169221-
OPPOSITION- Rowe Raymond C., Paul J Sheskey, Marian E Quinn , "Magnesium stearate. Sodium Lauryl Sulfate", Handbook of Pharmaceutical Excipients. 6th ed., PhP, (20090101), pages 404 - 407, 651-652, XP093187850-
OPPOSITION- Sakr Ahmed Adel, Et Al, "Chapter 30 oral solid dosage forms", Remington Essentials of Pharmaceutics, Pharmaceutical Press , (20120101), pages 581 - 610, XP055795831-
OPPOSITION- Tadej Battelino et al., "Liraglutide trial in paediatric subjects with type 2 diabetes: safety, tolerability and pharmacokinetics/pharmacodynamics", Diabetologia, Springer, Berlin, DE, Berlin, DE , (20121001), vol. 55, no. supplement 1, ISSN 1432-0428, page S7, XP009556384-
OPPOSITION- Troy, David B., "Chapter 35: Dissolution", Troy, David B., David B. Troy, Remington: The Science and Practice of Pharmacy, Lippincott Williams & Wilkins , (20050101), pages 672 - 690, ISBN 0781746736, XP009556365-
OPPOSITION- Troy, David B., "Chapter 35: Dissolution", Troy, David B., David B. Troy, Remington: The Science and Practice of Pharmacy, Lippincott Williams & Wilkins , (20050101), pages 672 - 690, ISBN 0781746736, XP009556365-
OPPOSITION- Troy, David B., "Chapter 53: Bioavailability and Bioequivalency Testing ", Troy, David B., David B. Troy, Remington: The Science and Practice of Pharmacy, Lippincott Williams & Wilkins , (20050101), pages 1037 - 1046, ISBN 0781746736, XP009556367-
OPPOSITION- Jack Y. Zheng, Robert L. Ternik, "Chapter 7: Development of Low-Dose Solid Oral Tablets Using Direct Compression", Jack Y. Zheng, Robert L. Ternik, Zheng Jack, Formulation and analytical development for low-dose oral drug products, Hoboken, N.J. , John Wiley & Sons, Inc. , (20090209), pages 159 - 204, doi:10.1002/9780470386361.ch7, ISBN 978-0-470-05609-7, XP055743688
OPPOSITION- Xiaorong He, Pamela J. Secreast, Gregory E. Amidon, "Mechanistic study of the effect of roller compaction and lubricant on tablet mechanical strength", Journal of Pharmaceutical Sciences, American Chemical Society and American Pharmaceutical Association, (20070501), vol. 96, no. 5, doi:10.1002/jps.20938, ISSN 00223549, pages 1342 - 1355, XP055060697
OPPOSITION- Renger F. Witkamp, "Current and Future Drug Targets in Weight Management", Pharmaceutical Research, Kluwer Academic Publishers-Plenum Publishers, NL, NL , (20101223), vol. 28, no. 8, doi:10.1007/s11095-010-0341-1, ISSN 1573-904X, pages 1792 - 1818, XP019921746
OPPOSITION- Charlotte Granhall, Morten Donsmark, Thalia M. Blicher, Georg Golor, Flemming L. Søndergaard, Mette Thomsen, Tine A. Bækdal, "Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes", CLINICAL PHARMACOKINETICS., ADIS INTERNATIONAL LTD., AUCKLAND, NZ, NZ , (20190601), vol. 58, no. 6, doi:10.1007/s40262-018-0728-4, ISSN 0312-5963, XP055545538
OPPOSITION- Michel Marre; Alfred Penfornis;, "GLP-1 receptor agonists today", DIABETES RESEARCH AND CLINICAL PRACTICE, AMSTERDAM, NL, NL , (20110106), vol. 93, no. 3, doi:10.1016/j.diabres.2011.01.004, ISSN 0168-8227, pages 317 - 327, XP028289489
OPPOSITION- Kleinebudde, P., "Roll compaction/dry granulation: pharmaceutical applications", European journal of pharmaceutics and biopharmaceutics, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM., NL, NL , (20040901), vol. 58, no. 2, doi:10.1016/j.ejpb.2004.04.014, ISSN 0939-6411, pages 317 - 326, XP004526315
OPPOSITION- Teng, Y. ; Qiu, Z. ; Wen, H., "Systematical approach of formulation and process development using roller compaction", European journal of pharmaceutics and biopharmaceutics, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM., NL, NL , (20091001), vol. 73, no. 2, doi:10.1016/j.ejpb.2009.04.008, ISSN 0939-6411, pages 219 - 229, XP026652682
OPPOSITION- C Beglinger, B PoIler, E Arbit, C Ganzoni, S Gass, I Gomez-Orellana, J Drewe, "Pharmacokinetics and Pharmacodynamic Effects of Oral GLP-1 and PYY3-36: A Proof-of-concept Study in Healthy Subjects", Clinical Pharmacology and Therapeutics, Nature Publishing Group, US, US , (20081001), vol. 84, no. 4, doi:10.1038/clpt.2008.35, ISSN 0009-9236, pages 468 - 474, XP008149454
OPPOSITION- R.E. STEINERT, B. POLLER, M.C. CASTELLI, K. FRIEDMAN, A.R. HUBER, J. DREWE AND C. BEGLINGER, "Orally Administered Glucagon-Like Peptide-1 Affects Glucose Homeostasis Following an Oral Glucose Tolerance Test in Healthy Male Subjects", Clinical Pharmacology and Therapeutics, Nature Publishing Group, US, US , (20091201), vol. 86, no. 6, doi:10.1038/clpt.2009.159, ISSN 0009-9236, pages 644 - 650, XP002635568
OPPOSITION- Stephen G. von EGGELKRAUT-GOTTANKA et al.,, "Roller Compaction and Tabletting of St. John's Wort Plant Dry Extract Using a Gap Width and Force Controlled Roller Compactor. I. Granulation and Tabletting of Eight Different Extract Batches", Phamaceutical Development and Technology, (2002), vol. 7, doi:10.1081/PDT-120015046, page 4, XP008166171
OPPOSITION- Stephen G. von EGGELKRAUT-GOTTANKA et al.,, "Roller Compaction and Tabletting of St. John's Wort Plant Dry Extract Using a Gap Width and Force Controlled Roller Compactor. II. Study of Roller Compaction Variables on Granule and Tablet Properties by a 3to3rd Factorial Design", Phamaceutical Development and Technology, (2002), vol. 7, doi:10.1081/PDT-120015047, page 4, XP008166170
OPPOSITION- von Eggelkraut-Gottanka Stephan G; Abed Salah Abu; Mueller Wolfgang; Schmidt Peter C, "Roller compaction and tabletting of St. John's wort plant dry extract using a gap width and force controlled roller compactor. II. Study of roller compaction variables on granule and tablet properties by a 3(3) factorial design.", PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, NEW YORK, NY, US, US , (20021101), vol. 7, no. 4, doi:10.1081/PDT-120015047, ISSN 1083-7450, pages 447 - 455, XP008166170
OPPOSITION- M. Kidron; S. Dinh; Y. Menachem; R. Abbas; B. Variano; M. Goldberg; E. Arbit; H. Bar‐On, "A novel per‐oral insulin formulation: proof of concept study in non‐diabetic subjects", DIABETIC MEDICINE., JOHN WILEY & SONS, LTD., GB, GB , (20040322), vol. 21, no. 4, doi:10.1111/j.1464-5491.2004.01160.x, ISSN 0742-3071, pages 354 - 357, XP071684198
OPPOSITION- STEINERT ROBERT E, ET AL, "Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects.", American Journal of Clinical Nutrition, Elsevier, (20101001), vol. 92, no. 4, doi:10.3945/ajcn.2010.29663, ISSN 0002-9165, pages 810 - 817, XP002677085

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents